U.S Class(es): 006, 018, 044, 046, 051, 052
Name | Novartis Pharma AG, |
---|---|
Address | Trademark Department Postfach CH-4002 Basel SWITZERLAND |
Date | Description | Action Tags | Code |
---|---|---|---|
Oct-16-2023 | TOTAL INVALIDATION PROCESSED BY THE IB | INNTP | |
Sep-27-2023 | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | INTSP | |
Sep-27-2023 | INVALIDATION PROCESSED | INPCP | |
Sep-20-2023 | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | INTRP | |
Jan-20-2023 | CANCELLED SECTION 71 | C71TO | |
Aug-26-2016 | NOTIFICATION PROCESSED BY IB | GPNXP | |
Aug-05-2016 | FINAL DISPOSITION NOTICE SENT TO IB | FICSP | |
Aug-05-2016 | FINAL DISPOSITION PROCESSED | FIMPP | |
Aug-04-2016 | GRANT OF PROTECTION CREATED, TO BE SENT TO IB | GPARP | |
Jul-05-2016 | REGISTERED-PRINCIPAL REGISTER | R.PRA | |
May-27-2016 | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED | ETOPT | |
Feb-11-2016 | EXTENSION OF TIME TO OPPOSE RECEIVED | ETOFT | |
Jan-12-2016 | PUBLISHED FOR OPPOSITION | PUBOA | |
Dec-24-2015 | NOTICE OF PUBLICATION | NPUBO | |
Dec-07-2015 | APPROVED FOR PUB - PRINCIPAL REGISTER | CNSAO | |
Dec-04-2015 | ASSIGNED TO EXAMINER | DOCKD | |
Nov-21-2015 | APPLICATION FILING RECEIPT MAILED | MAFRO | |
Nov-17-2015 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | NWOSI | |
Nov-16-2015 | LIMITATION FROM ORIGINAL APPLICATION ENTERED | LIMII | |
Nov-15-2015 | SN ASSIGNED FOR SECT 66A APPL FROM IB | REPRM |